Epstein-Barr virus and cancer

被引:572
作者
Thompson, MP [1 ]
Kurzrock, R [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA
关键词
D O I
10.1158/1078-0432.CCR-0670-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EBV was the first human virus to be directly implicated in carcinogenesis. It infects > 90 % of the world's population. Although most humans coexist with the virus without serious sequelae, a small proportion will develop tumors. Normal host populations can have vastly different susceptibility to EBV-related tumors as demonstrated by geographical and immunological variations in the prevalence of these cancers. EBV has been implicated in the pathogenesis of Burkitt's lymphoma, Hodgkin's disease, non-Hodgkin's lymphoma, nasopharyngeal carcinoma, and lymphomas, as well as leiomyosarcomas arising in immunocompromised individuals. The presence of this virus has also been associated with epithelial malignancies arising in the gastric region and the breast, although some of this work remains in dispute. EBV uses its viral proteins, the actions of which mimic several growth factors, transcription factors, and antiapoptotic factors, to usurp control of the cellular pathways that regulate diverse homeostatic cellular functions. Recent advances in antiviral therapeutics, application of monoclonal antibodies, and generation of EBV-specific CTLs are beginning to show promise in the treatment of EBV-related disorders.
引用
收藏
页码:803 / 821
页数:19
相关论文
共 316 条
[51]   Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2 [J].
Eliopoulos, AG ;
Blake, SMS ;
Floettmann, JE ;
Rowe, M ;
Young, LS .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1023-1035
[52]   Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production [J].
Eliopoulos, AG ;
Gallagher, NJ ;
Blake, SMS ;
Dawson, CW ;
Young, LS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16085-16096
[53]  
Eliopoulos AG, 1996, ONCOGENE, V13, P2243
[54]   Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) [J].
Eliopoulos, AG ;
Young, LS .
ONCOGENE, 1998, 16 (13) :1731-1742
[55]   VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITTS LYMPHOMA [J].
EPSTEIN, MA ;
ACHONG, BG ;
BARR, YM .
LANCET, 1964, 1 (733) :702-+
[56]   EXPRESSION OF EPSTEIN-BARR VIRUS-ENCODED PROTEINS IN NASOPHARYNGEAL CARCINOMA [J].
FAHRAEUS, R ;
FU, HL ;
ERNBERG, I ;
FINKE, J ;
ROWE, M ;
KLEIN, G ;
FALK, K ;
NILSSON, E ;
YADAV, M ;
BUSSON, P ;
TURSZ, T ;
KALLIN, B .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :329-338
[57]  
Farrell Paul J., 1995, Trends in Microbiology, V3, P105, DOI 10.1016/S0966-842X(00)88891-5
[58]   Signal transduction from the Epstein-Barr virus LMP-1 transforming protein [J].
Farrell, PJ .
TRENDS IN MICROBIOLOGY, 1998, 6 (05) :175-177
[59]  
FIORENTINO DF, 1991, J IMMUNOL, V146, P3444
[60]  
FRAPPIER L, 1994, J BIOL CHEM, V269, P1057